{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:13:17Z","timestamp":1776348797397,"version":"3.51.2"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T00:00:00Z","timestamp":1390262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086069","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T22:10:56Z","timestamp":1390342256000},"page":"e86069","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["IFN\u03b1 Serum Levels Are Associated with Endothelial Progenitor Cells Imbalance and Disease Features in Rheumatoid Arthritis Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Javier","family":"Rodr\u00edguez-Carrio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banesa","family":"de Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catuxa","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Alperi-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Ballina-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. annrheumdis-2011-200726 [pii];10.1136\/annrheumdis-2011-200726 [doi].","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"F Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hansel S, Lassig G, Pistrosch F, Passauer J (2003) Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 170: 177\u2013180. S0021915003002818 [pii].","DOI":"10.1016\/S0021-9150(03)00281-8"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2008.08.033","article-title":"Endothelial progenitor cells and cardiovascular homeostasis: clinical implications","volume":"131","author":"G Pompilio","year":"2009","journal-title":"Int J Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood.V95.10.3106","article-title":"In vitro differentiation of endothelial cells from AC133-positive progenitor cells","volume":"95","author":"UM Gehling","year":"2000","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","article-title":"Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors","volume":"95","author":"M Peichev","year":"2000","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/01.RES.0000205765.28940.93","article-title":"CD34\u2212\/CD133+\/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities","volume":"98","author":"EB Friedrich","year":"2006","journal-title":"Circ Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"JM Hill","year":"2003","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"N Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2631","article-title":"The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus","volume":"11","author":"LE Full","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"N Sattar","year":"2003","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"PH Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/hrt.2007.119271","article-title":"Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome","volume":"94","author":"A Malarstig","year":"2008","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/03009734.2011.624649","article-title":"The type I interferon system in the etiopathogenesis of autoimmune diseases","volume":"116","author":"L Ronnblom","year":"2011","journal-title":"Ups J Med Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"MF Denny","year":"2007","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"SG Thacker","year":"2010","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"SG Thacker","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"PY Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.30161","article-title":"How does interferon-alpha insult the vasculature? Let me count the ways","volume":"63","author":"MJ Kaplan","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"FK Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"ref21","first-page":"705","article-title":"ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology","volume":"26","author":"AM van Gestel","year":"1999","journal-title":"J Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"KK Ho","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","article-title":"TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"216","author":"L Rodriguez-Rodriguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/kes152","article-title":"Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients","volume":"51","author":"J Rodriguez-Carrio","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2008.091918","article-title":"EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells","volume":"68","author":"JH Distler","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"AK Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3150","article-title":"Type I IFN and TNFalpha cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance","volume":"12","author":"T Cantaert","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"BW Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e24828","DOI":"10.1371\/journal.pone.0024828","article-title":"Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis","volume":"6","author":"F Reynier","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/ard.2006.063412","article-title":"Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients","volume":"66","author":"TC van der Pouw Kraan","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/rheumatology\/ken299","article-title":"Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics","volume":"47","author":"CG Egan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","article-title":"Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis","volume":"111","author":"J Grisar","year":"2005","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2005.035378","article-title":"Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells","volume":"65","author":"K Herbrig","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"ref34","unstructured":"Allanore Y, Batteux F, Avouac J, Assous N, Weill B, <etal>et al<\/etal>.. (2007) Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol 25: 60\u201366. 1982 [pii]."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/ar2934","article-title":"Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity","volume":"12","author":"dV Jodon","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3899\/jrheum.090782","article-title":"Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification","volume":"37","author":"KH Yiu","year":"2010","journal-title":"J Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/annrheumdis-2012-201334","article-title":"How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?","volume":"71","author":"AM Kerola","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"KA Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/rheumatology\/kep345","article-title":"Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis","volume":"49","author":"T Cantaert","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pmed.0030491","article-title":"Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus","volume":"3","author":"JW Bauer","year":"2006","journal-title":"PLoS Med"},{"key":"ref41","article-title":"Identification of molecular pathways associated with progression of carotid atherosclerosis in systemic lupus erythematosus [abstract]","volume":"54","author":"KA Kirou","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e37000","DOI":"10.1371\/journal.pone.0037000","article-title":"Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients","volume":"7","author":"EC Somers","year":"2012","journal-title":"PLoS One"},{"key":"ref43","first-page":"582","article-title":"Type I Interferon gene signatures are associated with vascular risk and atherosclerosis in systemic lupus erythematosus [abstract]","volume":"60","author":"W Zhao","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2169\/internalmedicine.31.936","article-title":"Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon","volume":"31","author":"T Kobayashi","year":"1992","journal-title":"Intern Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00000441-200212000-00008","article-title":"A case of reversible dilated cardiomyopathy after alpha-interferon therapy in a patient with renal cell carcinoma","volume":"324","author":"A Kuwata","year":"2002","journal-title":"Am J Med Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"JM Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 levels in patients with rheumatoid arthritis","volume":"38","author":"JJ Cush","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02238963","article-title":"Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins","volume":"16","author":"JK Lacki","year":"1997","journal-title":"Clin Rheumatol"},{"key":"ref49","unstructured":"Lopez P, Gomez J, Prado C, Gutierrez C, Suarez A (2008) Influence of functional interleukin 10\/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J Rheumatol 35: 1559\u20131566. 08\/13\/0621 [pii]."},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.34483","article-title":"Large-scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus","volume":"64","author":"CE Weckerle","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/art.23728","article-title":"The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus","volume":"58","author":"SN Kariuki","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00296-009-1156-4","article-title":"Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage","volume":"30","author":"XL Deng","year":"2010","journal-title":"Rheumatol Int"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/rheumatology\/ken286","article-title":"Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells","volume":"47","author":"J Grisar","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar2912","article-title":"Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment","volume":"12","author":"LG van Baarsen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.24557","article-title":"Neutralization of interferon-alpha\/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus","volume":"60","author":"Y Yao","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T11:34:53Z","timestamp":1597404893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086069"}},"subtitle":[],"editor":[{"given":"Peter","family":"Szodoray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086069","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}